44th Annual J.P. Morgan Healthcare Conference
Logotype for Merck KGaA

Merck (MRK) 44th Annual J.P. Morgan Healthcare Conference summary

Event summary combining transcript, slides, and related documents.

Logotype for Merck KGaA

44th Annual J.P. Morgan Healthcare Conference summary

16 Jan, 2026

Strategic positioning and growth pillars

  • Positioned for growth in innovation-driven and secular markets, focusing on Process Solutions, rare diseases, and Semiconductor Solutions as key growth drivers.

  • Multi-industry model and diversified global footprint provide resilience amid geopolitical changes.

  • M&A and disciplined portfolio management remain central, with recent acquisitions like SpringWorks and divestments such as Surface Solutions, supported by strong cash generation.

  • Three sectors—Life Science, Healthcare, and Electronics—target highly innovative end-markets.

  • Key growth drivers expected to contribute up to 80% of future growth.

Sector performance and outlook

  • Life Science sector reorganized for customer-centricity, with three go-to-market models: Process Solutions, Advanced Solutions, and Discovery Solutions, and a new structure effective January 2026.

  • Process Solutions expected to grow 9%-10% midterm, driven by demand for monoclonal antibodies and novel modalities.

  • Healthcare focuses on rare diseases, oncology, and fertility, with new launches and pipeline advancements.

  • Electronics sector leverages semiconductor and optronics solutions, with AI and advanced nodes driving mid-term growth.

  • Advanced Solutions and Discovery Solutions forecasted for mid- to high-single-digit and low-single-digit growth, respectively.

Pipeline, innovation, and M&A

  • Rare disease portfolio includes Ogsiveo, Gomekli, and pimicotinib, with combined peak sales potential of €2.5 billion and multiple launches planned through 2027.

  • Pipeline replenishment strategy emphasizes external innovation, aiming for 50% of new launches from outside sources.

  • Ongoing openness to in-licensing and bolt-on M&A, especially in rare diseases.

  • Electronics sector, especially Semiconductor Solutions, benefits from AI-driven demand and advanced packaging, with over 50% of the portfolio in advanced nodes.

  • M&A strategy remains focused on innovation-driven businesses, using a string of pearls approach for targeted acquisitions.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more